Renaissance Technologies' Q3 2026 13F shows the quant giant cutting Nvidia by 99.7% and rotating into Micron, AMD and SpaceX, and here's how to read a quant fund's filing without overreacting.
Early Q3 2026 13F filings show big banks growing their spot bitcoin ETF and Strategy positions, while Renaissance Technologies headed for the exit, and here's how to read those moves.
Fidelity's giant Q3 13F shows a 9% cut to its Nvidia stake, smaller SpaceX and Amazon positions, and a bigger bet on Strategy, and here's how to read those moves in context.
SK Hynix's Nasdaq-listed ADRs (SKHY) began trading in July, which makes Q3 2026 13F filings the first full look at which US institutions bought into the AI memory leader.
Second-quarter 13F filings point to hedge funds broadening and rotating their AI exposure, not de-risking, with SpaceX, Alphabet and Amazon gaining while Nvidia and Broadcom saw selling.
Duquesne Family Office's Q2 2026 13F shows a broad rotation: Broadcom and Coherent exited, Amazon boosted sharply, and dozens of new cyclical positions opened.
Space Exploration Technologies (SPCX) debuted in 34 of 299 focused 13F books in Q2 2026, and the data shows who went big and what it does and doesn't mean.
13F filings show only long US-listed equity positions at quarter-end, so a hedge fund's shorts, hedges and foreign holdings are invisible; here is how to read around the gaps.
A position that disappears from a 13F is not always a vote of no confidence: mergers, buyouts and index changes can erase a holding without a single sell decision.
The Big Three index giants top almost every 13F ownership table, but their positions say little about conviction. Here is how to separate passive noise from real signal.
Cerebras (CBRS) was one of the most-opened positions in Q2 2026 13F filings; here is who owns it and what a first-quarter holder list can and cannot tell you.
Micron was one of the most-opened positions in Q2 2026 13F filings, yet David Tepper sold 41% of his stake — a case study in reading the same stock two ways.
Big banks kick off Q3 earnings this week, making it the ideal moment to check whether the stocks hedge funds bought in Q2 are still earning their place.
Microsoft, Nvidia, Amazon and Apple appear on both the most-bought and most-sold lists in Q2 2026 13F data, and here is how to read that apparent contradiction.
Li Lu's Himalaya Capital made two adds and six cuts in Q2 2026, buying PDD Holdings and Berkshire while exiting Bank of America and the ratings agencies.
Soros Fund Management's Q2 2026 13F shows a nearly eightfold increase in Micron just as Renaissance, Bridgewater, and Appaloosa were heading for the exits.
Citadel's Q2 2026 13F shows Ken Griffin trimming Nvidia, Broadcom, and Micron while adding aggressively to Amazon and Microsoft — a bet on AI monetization over AI spending.
Paul Singer's Elliott Investment Management dramatically expanded its bearish options bet on the Nasdaq in Q2 2026, and its 13F reveals a portfolio built to survive an AI unwind.
Appaloosa's Q2 2026 13F shows put options on Apple and Berkshire Hathaway, and the way those lines are reported makes them easy to misread as bullish buys.
International equities have outrun US stocks for two years running, but Form 13F only reports US-listed securities — leaving the decade's largest rotation visible only through ADRs and ETF wrappers.
The best-performing AI exposure of 2026 wasn't a semiconductor — it was a bulldozer and a gas turbine, and the 13F record shows institutions arriving at that conclusion unevenly.
The third quarter delivered one of the sharpest value-over-growth rotations in years, and the 13Fs that land in November will show the destination without showing who arrived late.
Viking, Lone Pine, Coatue and Durable all piled into Carvana in the second quarter — a convergence that says more about the growth-fund playbook than about used cars.
Institutions have quietly built positions in nuclear operators and SMR developers as the AI power thesis matured — but one FERC ruling exposed the risk 13F data cannot price.
The Gates Foundation Trust filed one of the quarter's most revealing 13Fs — a completed Microsoft exit, a 14% Berkshire cut, and a brand-new spinoff bought within weeks of listing.
Baupost's new position in Pershing Square is small in dollars but large in meaning — and it points at a broader 13F question about who owns the asset managers.
Confidential treatment requests let managers delay disclosing their best ideas for up to a year — and the positions they hide tend to be the ones that work.
Copper hit all-time highs in August 2026 on data-center and grid demand, but institutional exposure to the miners still looks thin in Q2 filings — a gap worth understanding.
Berkshire, Klarman, Tepper, Druckenmiller and Loeb all added Alphabet in Q2 2026 — a rare agreement between investing styles that usually contradict each other.
European rearmament is the largest defense build-up since the Cold War, and almost none of it shows up in 13F filings — which changes how you should read institutional positioning in the sector.
Greg Abel ended a 14-quarter net-selling streak in Q2 2026, and the shopping list was Lennar, D.R. Horton, Delta and Macy's — not the trade the rest of the market was making.
XLE was up roughly 30% year-to-date by late August, yet 13F filers cut their share count in the quarter — a case study in how underweight positioning and a supply shock collide.
The Russell 2000 has led the market for most of 2026, but the structure of 13F reporting means institutional filings barely register it — and that gap is worth understanding.
While everyone argued about AI capex, institutional money rotated into banks, insurers and emerging-market fintech — and the Q2 13F filings show it clearly.
Institutional buyers piled into power utilities last quarter as the AI trade moved down the stack — but a defensive sector bought for offensive reasons carries risks the 13F data doesn't show.
Third Point's Q2 2026 13F shows a complete exit from every chip name Loeb owned, with the proceeds redirected into Warner Bros. Discovery, Alphabet, and SpaceX.
Q2 2026 13F filings reveal a split personality in institutional crypto — hedge funds trimmed Bitcoin ETFs while quietly loading up on crypto-adjacent equities like Bitdeer and Hyperliquid Strategies.
SpaceX went public in June and by the Q2 filing deadline it was the single largest position at multiple major hedge funds — one of them at over 60% of its disclosed book.
Pershing Square exited Alphabet and opened four new positions in Visa, Mastercard, S&P Global, and Netflix — a quiet shift from AI winners to fee-collecting compounders.
While institutional investors argued over AI, gold quietly suffered a 20% drawdown — and Q2 13F filings reveal a split between funds who sold the miners and funds who added.
Q2 2026 13F filings confirm a rotation that prime brokerage data flagged weeks ago — institutional money is piling into healthcare at the fastest pace in five years.
July's tech sell-off exposed how crowded the AI trade has become — here's how to use the upcoming Q2 13F filings to map the crowding before it unwinds further.
Hedge funds dumped chip and memory stocks in July, so the June 30 snapshots arriving on August 14 need careful reading — here's how to extract real signal anyway.
Amazon's Q2 earnings beat — with AWS growing 37% — rewarded the hedge fund managers who piled into AMZN in Q1, including Ackman, Tepper, and Berkshire.
Pershing Square is trailing the S&P 500 by nearly 19 points this year — here's what Ackman's concentrated book looks like and what it teaches anyone who follows 13F filings.
Stanley Druckenmiller's Q1 2026 13F shows a 25% cut in U.S. exposure, a doubling-down on genetic testing leader Natera, and a growing basket of international names.
Warren Buffett plans to dispose of his entire $140 billion Berkshire stake by 2034 — here's what it means for the portfolio 13F trackers follow most closely.
Berkshire exited and Tepper slashed UNH in Q1 2026 — then UnitedHealth crushed Q2 earnings. What the filings got right, wrong, and what the lag teaches us.
Q1 13F filings flagged SanDisk months before its historic rally. Here's who bought SNDK early, why the NAND supercycle keeps running, and what to watch in Q2 filings.
Q2 13F filings land by August 14 — here are the five questions that will decide whether the great AI hardware rally was smart money or momentum chasing.
TCI Fund Management slashed its Microsoft stake by 84% in Q1 2026 and rotated into Alphabet — a rare AI-driven pivot from one of Wall Street's most concentrated portfolios.
Q1 2026 13F filings show biotech specialist funds like ADAR1 Capital making concentrated bets on gene editing and rare-disease names — here's what the healthcare smart money is telling us.
Citadel Advisors' Q1 2026 13F shows Nvidia, Tesla, Apple, and gold at the top — but market-maker filings hide more than they reveal, and knowing the difference is the whole game.
Scion Asset Management's latest 13F shows Michael Burry dumping his entire Chinese tech basket, initiating MercadoLibre and beaten-down SaaS names, and doubling down on bearish AI bets.
Q1 2026 13F filings reveal a striking convergence: top hedge funds are betting that the real bottleneck of the AI boom isn't chips or software — it's electricity.
Ray Dalio's $92B firm made its biggest sector rotation in years — loading up on NVIDIA, Broadcom, Micron, and TSMC while dumping Salesforce, Workday, and Adobe.
In his debut quarter as Berkshire CEO, Greg Abel tripled the Alphabet stake, bought Delta Air Lines, and cut the portfolio from 40 positions to just 26 — signaling a sharper, more concentrated Berkshire.
Third Point's Q1 2026 13F reveals a sweeping portfolio overhaul — 19 positions liquidated, hard assets and semiconductor equipment added, and a clear bet on the next leg of the AI trade.
Pershing Square's surprise Microsoft stake — and the simultaneous Alphabet exit — is one of the most telling institutional moves in the Q1 2026 13F filing cycle.
Greenlight Capital returned 6.5% in Q1 2026 while the S&P 500 fell 4.4%, driven by gold, healthcare, and a massive concentrated bet on homebuilder Green Brick Partners.
Oaktree's Q1 2026 13F shows Howard Marks loading up on gold miners, energy hedges, and a $551 million put overlay — a portfolio built for caution, not conviction.
Stanley Druckenmiller's Q1 2026 13F shows a full exit from Alphabet and a sweeping rotation into semiconductor and AI-hardware names, alongside a surprising bet on genomic testing and Argentina.
Bill Ackman and David Tepper both filed their Q1 2026 13Fs in May — here's what they're betting on together, and where their convictions sharply diverge.
David Tepper's Appaloosa Management made sweeping changes in Q1 2026 — tripling Micron, surging into Amazon and Uber, and dumping all airline exposure. Here's what the 13F data reveals.
Leopold Aschenbrenner's Situational Awareness LP Q1 2026 13F reveals a bold, contrarian wager: short semiconductors, go long on power and compute infrastructure.
Greg Abel's debut 13F shows a dramatically slimmer, tech-heavier Berkshire — 16 stocks sold, Alphabet tripled, and Delta Air Lines added as a major new bet.
The Q1 2026 13F filing reveals Greg Abel's bold opening moves at Berkshire Hathaway — tripling Alphabet, ditching Visa and Mastercard, and cutting the portfolio from 40 holdings to 29.
Q1 2026 13F filings are in. Here's what top hedge funds and institutional investors actually bought, sold, and concentrated into — and what it means for retail investors watching the smart money.
When Warren Buffett, Bill Ackman, and other top investors all hold the same stock, it's worth paying attention. Here's how to find high-conviction overlap plays using public 13F data.
Bill Ackman and David Tepper made strikingly similar moves in Q1 2026 — both doubling down on Amazon while slashing exposure to travel, retail, and old-economy names.
Berkshire Hathaway's latest SEC 13F filing reveals where Warren Buffett is allocating capital in Q1 2026 — and what it signals about his macro outlook.